Hims & Hers Health, Inc. HIMS
Sales up 59.0%, free cash flow down to $57.4M
XBRL, from each 10-KThe latest figures
Price and key numbers
All key numbers (38, from the latest 10-K and 10-Q)
- EPS (ttm)
- -0.83
- Sales (ttm)
- 2.9B
- Net income (ttm)
- -190.8M
- Sales growth
- +59.0%
- EPS growth
- -3.8%
- Sales Q/Q
- +48.6%
- Free cash flow
- 8.2M
- Gross margin
- 63.8%
- Oper. margin
- -8.1%
- Net margin
- -6.7%
- FCF margin
- 0.3%
- ROE
- -53.7%
- ROA
- -5.4%
- R&D / sales
- -
- Dividend
- -
- Debt/Eq
- -
- Curr. ratio
- 0.92
- Cash
- 605.6M
- Op. cash flow (ttm)
- 180.1M
- EBITDA
- 160.1M
- EBITDA margin
- 6.8%
- Quick ratio
- 0.86
- ROIC
- 30.8%
- FCF after stock pay
- -77.8M
- Goodwill / assets
- 12.9%
- Oper. margin low 5y
- -42.3%
- Tax rate
- -3.6%
- Stock pay / sales
- 5.8%
- Shares out.
- 233.8M
- Shares Y/Y
- +9.0%
- Book / share
- 1.52
- Cash / share
- 2.59
- Sales / share
- 12.27
- Asset turnover
- 0.81
- Inventory turns
- 7.67
- Days sales out.
- 5
- Sales 3Y CAGR
- +64.5%
- Sales 5Y CAGR
- +73.6%
Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.
Revenue and net income, FY2019 to FY2025
Each fiscal year from its own 10-K · XBRL
From XBRL in each 10-K. Hover a bar for the line item and filing. "A year" is the steady yearly growth from FY2019 to FY2025 (6 years).
What the balance sheet holds, per share
Net current asset value and tangible book value, FY2025 · 10-K XBRL, no share price used
- + Shareholders' equity $540.9M
- − Goodwill $278.3M
- − Other intangible assets $196.1M
- = Tangible book value $66.5M
Net current asset value is current assets minus all liabilities (the long-term ones too), so it is what would be left from the short-term assets after everything owed is paid; it is blank for a bank, which reports no current assets. Tangible book value is shareholders' equity minus goodwill and other intangible assets; equity includes any preferred stock. Both are divided by the diluted weighted-average share count of the same fiscal year. Red bars are amounts taken off, or a negative result.
HIMS against Health care peers
Among the 162 companies, the better end on the right. The band holds the middle half; the line is the median.
| Company | Revenue (ttm) | Sales growthFY | Gross marginttm | Net marginttm | ROEttm | FCF marginttm | Debt / equitylatest |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health, Inc. | $2.9B | +59.0% | 63.8% | -6.7% | -53.7% | 0.3% | - |
| BKD Brookdale Senior Living Inc. | $2.9B | +2.2% | 27.6% | -1.3% | - | 0.5% | - |
| RVTY Revvity | $2.9B | +3.7% | - | 8.6% | 3.5% | 20.1% | 0.36 |
| NTRA Natera, Inc. | $2.9B | +35.9% | - | -5.7% | -8.8% | 1.8% | 0.04 |
| NVST Envista Holdings Corp | $2.9B | +8.3% | 55.9% | 22.0% | 20.5% | 8.4% | 0.46 |
| MEDP Medpace Holdings, Inc. | $2.8B | +20.0% | - | 18.2% | 88.5% | 23.5% | - |
Where each dollar goes
Revenue through the costs to the net profit, from the 10-K income statement and revenue by region
From $1.5B of sales to $126.0M of profit FY2024
- Federal $1.4B
- Foreign $26.8M
From $2.3B of sales to $128.4M of profit FY2025
- Federal $2.2B
- Foreign $134.0M
Where each $100 of sales went
- Cost of revenue
- Costs, tax, other
- Net profit
Band widths are the money. Gross profit is revenue less cost of revenue; operating expenses are gross profit less operating profit; R&D is from the income statement and the rest of the operating expenses is everything else; tax includes interest and other items when they are small. Y/Y is the change from the fiscal year before. Revenue by part only for the years in the last two 10-Ks' segment tables. The full income statement
Where the return on equity comes from
DuPont: net margin × asset turnover × leverage, FY2025 against FY2021 · 10-K XBRL, year-end balances
The three parts multiply to the return on equity. A higher return from leverage alone means more debt or less equity (buybacks shrink equity), not a better business. Year-end balances as filed, not averages, so each number is one line of one 10-K; hover a box for its XBRL tags.
Profitability
-
Net margin below the peer median-6.7% vs 6.8%
-
Gross margin up over 5 years73.6% → 73.8%
-
Return on equity below 15%-53.7%
-
A profit in 2 of 7 years
Cash and shareholders
-
Free cash flow positive in 3 of 4 years$57.4M last year
-
Share count up over 5 years+46.1%
-
Cash from operations above net income$300.0M vs $128.4M
Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.
Contracted revenue and deferred revenue
Backlog (remaining performance obligations) and cash received in advance, by balance sheet date · XBRL
Contract liabilities, current part
Paid in advance $144.1M cash received before delivery, not yet recognized as revenue, Sep 30, 2026 · +21.6% on a year earlierBoth are balance-sheet-date values from the 10-K and 10-Qs. Backlog is what is under contract, not a forecast: contracts can be cancelled or change in size, and a company counts them in its own way. Hover a number for its XBRL line; click it to open the filing.
Income statement, balance sheet and cash flow
Statements · XBRL, each 10-K and 10-Q
HIMS's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year, the last 7. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.
Revenue by region
year to Dec 31, 2025| Revenue | Share | vs year before | |
|---|---|---|---|
| Federal | 2.2B | 94.3% | +52.7% |
| Foreign | 134.0M | 5.7% | +399% |
10-K 0001773751-26-000022, segment and revenue notes (XBRL).
Income statement
From EDGAR| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 82.6M | 148.8M | 271.9M | 526.9M | 872.0M | 1.5B | 2.3B |
| Cost of revenue | 38.0M | 39.3M | 67.4M | 118.2M | 157.1M | 303.4M | 614.3M |
| Gross profit | 44.6M | 109.5M | 204.5M | 408.7M | 714.9M | 1.2B | 1.7B |
| SG&A | 55.9M | 65.6M | 183.6M | 98.2M | 129.9M | 167.8M | 272.7M |
| Operating income | -74.4M | -15.1M | -115.0M | -68.7M | -29.5M | 61.9M | 105.6M |
| Interest expense | 369K | 10K | 0 | 0 | - | - | - |
| Pretax income | -72.0M | -18.0M | -110.8M | -65.7M | -21.6M | 71.7M | 123.9M |
| Income tax | 90K | 127K | -3.1M | -31K | 2.0M | -54.3M | -4.4M |
| Net income | -72.1M | -18.1M | -107.7M | -65.7M | -23.5M | 126.0M | 128.4M |
| EPS (diluted) | -2.07 | -0.51 | -0.58 | -0.32 | -0.11 | 0.53 | 0.51 |
| Diluted shares | 34.8M | 35.4M | 186.8M | 204.5M | 209.3M | 236.8M | 258.2M |
| Depreciation & amortization | 260K | 1.1M | 4.1M | 7.5M | 9.5M | 17.1M | 54.5M |
| EBITDA | -74.2M | -14.1M | -111.0M | -61.2M | -19.9M | 79.0M | 160.1M |
| Gross margin | 54.0% | 73.6% | 75.2% | 77.6% | 82.0% | 79.5% | 73.8% |
| Operating margin | -90.1% | -10.2% | -42.3% | -13.0% | -3.4% | 4.2% | 4.5% |
| Net margin | -87.3% | -12.2% | -39.6% | -12.5% | -2.7% | 8.5% | 5.5% |
| Revenue growth | - | +80.2% | +82.8% | +93.8% | +65.5% | +69.3% | +59.0% |
| EPS growth | - | - | - | - | - | - | -3.8% |
Balance sheet
From EDGAR| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash | 22.6M | 27.3M | 71.8M | 46.8M | 96.7M | 220.6M | 228.6M |
| Short-term investments | 37.7M | 72.9M | 175.5M | 132.9M | 124.3M | 79.7M | 348.9M |
| Receivables | - | 1.1M | 4.1M | 3.9M | 6.7M | 6.1M | 32.1M |
| Inventory | 4.2M | 3.5M | 13.6M | 21.6M | 22.5M | 64.4M | 80.1M |
| Current assets | 69.6M | 113.1M | 269.9M | 216.6M | 265.1M | 395.8M | 767.6M |
| Property & equipment | - | 1.7M | 2.2M | 3.0M | - | - | - |
| Goodwill | - | 0 | 110.9M | 110.9M | 110.9M | 112.7M | 278.3M |
| Other intangible assets | - | 59K | 25.9M | 21.8M | 18.6M | 43.4M | 196.1M |
| Total assets | 72.1M | 118.7M | 420.6M | 366.3M | 441.2M | 707.5M | 2.2B |
| Accounts payable | 7.2M | 8.1M | 19.6M | 32.4M | 43.1M | 91.2M | 143.3M |
| Current liabilities | 20.6M | 15.2M | 79.2M | 47.9M | 88.5M | 221.4M | 404.4M |
| Total debt | 1.5M | 0 | - | - | - | - | - |
| Total liabilities | 20.6M | 15.6M | 86.0M | 54.6M | 97.2M | 230.8M | 1.6B |
| Shareholders' equity | -139.8M | -146.9M | 334.6M | 311.7M | 344.0M | 476.7M | 540.9M |
| Retained earnings | -153.2M | -171.3M | -279.0M | -344.6M | -368.2M | -242.1M | -113.8M |
Cash flow
From EDGAR| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -74.9M | -2.5M | -34.4M | -26.5M | 73.5M | 251.1M | 300.0M |
| Capital spending | - | - | - | 7.2M | 26.5M | 52.8M | 242.6M |
| Free cash flow | - | - | - | -33.7M | 47.0M | 198.3M | 57.4M |
| Stock-based pay (added back) | 8.0M | 5.8M | 67.2M | 42.8M | 66.1M | 92.3M | 135.2M |
| Free cash flow after stock pay | - | - | - | -76.5M | -19.1M | 106.0M | -77.8M |
| Buybacks | 0 | 0 | 0 | 0 | 2.0M | 83.0M | 90.0M |
| Acquisitions | 0 | 0 | 46.5M | 0 | 0 | 15.4M | 145.2M |
| Debt raised | 2.1M | 0 | 0 | - | 0 | 0 | 970.0M |
| Debt repaid | 9.1M | 1.5M | 0 | 0 | - | - | - |
| Investing cash flow | -39.3M | -39.7M | -156.3M | 34.7M | -12.1M | -19.0M | -1.0B |
| Financing cash flow | 95.3M | 47.7M | 235.0M | -33.1M | -11.5M | -107.8M | 729.6M |
Stock-based pay and leases
From EDGAR| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Stock-based pay (expense) | 8.0M | 5.8M | 67.2M | 42.8M | 66.1M | 92.3M | 135.2M |
| Stock-based pay / revenue | 9.7% | 3.9% | 24.7% | 8.1% | 7.6% | 6.3% | 5.8% |
| Operating lease cost | - | - | 1.8M | 1.9M | 2.4M | 3.0M | 13.5M |
| Operating lease cash paid | - | - | 1.5M | 1.6M | 1.9M | 2.4M | 1.9M |
| Right-of-use assets | - | 0 | 5.1M | 4.9M | 9.6M | 10.9M | 137.0M |
| Operating lease liabilities | - | 0 | 5.5M | 5.3M | 9.9M | 11.3M | 148.0M |
From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.
Sources
Every figure is from the company's XBRL filed with each 10-K and 10-Q (data.sec.gov). Hover a number for its line item; click it to open the filing.
Also
Company numbers: the figures the company reports beyond the statements. Peers: ten years, side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HIMS/export.csv") into a cell.